Caxton Associates LP Pet Iq, Inc. Transaction History

Caxton Associates LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$15.93 - $22.26 $286,628 - $400,524	-17,993 Reduced 57.05%	13,544 $298,000
Q1 2024 May 15, 2024	SELL	$15.55 - $19.42 $56,337 - $70,358	-3,623 Reduced 10.3%	31,537 $576,000
Q4 2023 Feb 14, 2024	BUY	$17.18 - $22.38 $226,982 - $295,684	13,212 Added 60.2%	35,160 $694,000
Q3 2023 Nov 14, 2023	BUY	$15.0 - $20.71 $329,220 - $454,543	21,948 New	21,948 $432,000

189

30M

81K

113K

Ticker PETQ
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,312,800
Market Cap $908M
Description
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.